An FDA advisory panel voted in July 2026 to ease compounding of peptides like BPC-157 and TB-500. What the recommendation means, and what it does not.
CATEGORY ARCHIVE
Peptides
Peptide therapy for healing, anti-aging, sports recovery, and regenerative treatments.
Peptide Therapy for Sports Injury: What the 2026 Evidence and FDA Review Show
Peptide therapy for sports injury in 2026: what BPC-157, TB-500, and the science actually show, the FDA compounding review, WADA rules, and how to vet quality.
Regenerative Medicine for Arthritis: Your Guide to Modern Treatment Options
Explore how regenerative medicine for arthritis offers new hope through exosome therapy, stem cell treatments, and peptide protocols. Learn about modern alternatives to surgery and long-term medication.
Peptide Therapy for Recovery and Healing: A Complete Guide
Discover how peptide therapy supports tissue repair, immune function, and recovery. Learn about BPC-157, CJC-1295, Thymosin Alpha-1, and more in this comprehensive guide.
FDA Peptide Reclassification 2026: What the Changes Mean for Patients and Practitioners
On February 27, 2026, HHS Secretary Robert F. Kennedy Jr. announced a major shift in federal peptide policy:...